Investment analysts at StockNews.com began coverage on shares of Athersys (NASDAQ:ATHX – Get Free Report) in a research note issued on Saturday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock.
Athersys Price Performance
Athersys has a 52 week low of $0.01 and a 52 week high of $1.99. The company has a market capitalization of $833,000.00, a price-to-earnings ratio of 0.00 and a beta of -0.90.
About Athersys
Want More Great Investing Ideas?
See Also
- Five stocks we like better than Athersys
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Nextracker’s Solar Surge: Will It Shatter Its All-Time High?
- What Investors Need to Know to Beat the Market
- Savvy Investors Are Raising a Glass for Heineken Stock
- What is MarketRankâ„¢? How to Use it
- Top 4 ETFs for China Exposure After Tariff Relief
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.